Mixed Kinetic Model of Inhaled Corticosteroid Dissolution
Explore the dissolution kinetics of inhaled pharmaceuticals in dry powder inhalers (DPI) and pressurized metered dose inhalers (pMDI).
Automated Classification of DPI Agglomerate Particles
Explore automated classification of dry powder inhaler particles using Cluster Analysis and Morphologically Directed Raman Spectroscopy.
Alternative regulatory path for generic Respiratory Products
Explore Nanopharm’s SmartTrack, an alternative solution for FDA approval of generic inhalation drug delivery products.
Challenges in OINDPs Achieving Q3 Equivalence
Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.
Trade Marks Registration Certificate for Nanopharm Ltd
Discover Nanopharm’s leading role in pharmaceutical research, specializing in OINDP, nasal, and inhaled pharmaceutical solutions.
Structural Dynamics of Fluticasone Propionate Processing
Nanopharm explores the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate.
Secondary Processing’s Effect on Fluticasone Dynamics
Explore the effect of secondary processing on the structural relaxation dynamics of Fluticasone Propionate in DPIs.
Cohesive-Adhesive Balances in DPIs
Explore Dry Powder Inhaler development through Atomic Force Microscopy. Uncover Cohesive-Adhesive balances in OINDP for effective inhaler formulations.
